Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Dr. Abdulraheem Yacoub is a professor of Hematologic malignancies and Cellular Therapies at the University of Kansas School of Medicine. Dr. Yacoub earned his medical degree from Jordan University in Amman, Jordan, in 2003 before completing a hematology-oncology fellowship at the University of Arkansas. Dr. Yacoub is internationally recognized for his work in myeloproliferative neoplasms; his clinic at the University of Kansas is recognized as both a Key member of the NIH-funded consortium dedicated to the research of MPNs as well as an MPN Center of Excellence. Dr. Yacoub has been honored through numerous awards and invitations to speak throughout his career. He also serves as the lead global clinical investigator and global lead for the LIMBER clinical trials, which aim to refine the most effective upfront therapy in myelofibrosis.